SUTENT® 12,5 mg CAPSULES


Capsule
scheduling status
S4
registration number
41/26/0197
What SUTENT® 12,5 mg CAPSULES contains
Sunitinib (as malate).
other ingredients
Capsule contents Croscarmellose sodium Magnesium stearate Mannitol (E421) Povidone Capsule shell Gelatin Red iron oxide (E172) Titanium dioxide (E171) Imprinting ink Povidone Propylene glycol Shellac Sodium hydroxide Titanium dioxide (E171).
Therapeutic classification
L01EX01.
© 2026 SAHPRA. ALL RIGHTS RESERVED